Protagenic Therapeutics, Inc.\new Comprehensive Income
Protagenic Therapeutics, Inc.\new (PTIX) reported Comprehensive Income of -$962.51 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$962.51K.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $4.83M.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $2.21M.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$832.42K.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was $1.04M.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$3.62M.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$5.54M.
- Protagenic Therapeutics, Inc.\new comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$4.44M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$962.51K 10-Q · filed 2026-08-19 | $3.87M derived: sum of 2 quarters · filed 2026-08-19 | $6.08M derived: sum of 3 quarters · filed 2026-08-19 | $5.25M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2026-03-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | $7.04M derived: sum of 2 quarters · filed 2026-08-14 | $6.21M derived: sum of 3 quarters · filed 2026-08-14 | $1.04M 10-K · filed 2026-08-14 | |
| 2025-12-31 | $2.21M 10-Q · filed 2026-03-09 | $1.38M derived: sum of 2 quarters · filed 2026-03-09 | -$3.80M 10-Q · filed 2026-03-09 | -$5.12M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-09-30 | -$832.42K 10-Q · filed 2025-11-26 | -$5.89M 10-Q · filed 2025-11-26 | -$7.33M derived: sum of 3 quarters · filed 2026-08-19 | -$8.18M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-06-30 | -$5.06M 10-Q · filed 2026-08-19 | -$6.50M derived: sum of 2 quarters · filed 2026-08-19 | -$7.35M derived: sum of 3 quarters · filed 2026-08-19 | -$8.06M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-03-31 | -$1.44M 10-Q · filed 2025-05-13 | -$2.29M derived: sum of 2 quarters · filed 2026-03-09 | -$3.00M derived: sum of 3 quarters · filed 2026-03-09 | -$3.62M 10-K · filed 2026-08-14 | |
| 2024-12-31 | -$847.54K 10-Q · filed 2026-03-09 | -$1.56M derived: sum of 2 quarters · filed 2026-03-09 | -$1.89M 10-Q · filed 2026-03-09 | -$5.54M 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$717.39K 10-Q · filed 2025-11-26 | -$640.87K 10-Q · filed 2024-11-14 | -$1.05M 10-Q · filed 2025-11-26 | -$3.99M 10-Q · filed 2024-11-14 | -$3.91M derived: sum of 4 quarters · filed 2025-11-26 |
| 2024-06-30 | -$324.36K 10-QT · filed 2025-09-10 | -$1.65M 10-Q · filed 2024-08-14 | -$3.35M 10-Q · filed 2024-08-14 | -$3.19M derived: sum of 3 quarters · filed 2025-09-10 | -$4.62M derived: sum of 4 quarters · filed 2025-09-10 |
| 2024-03-31 | -$1.70M 10-Q · filed 2025-05-13 | -$2.87M derived: sum of 2 quarters · filed 2025-05-13 | -$4.30M derived: sum of 3 quarters · filed 2025-05-13 | -$5.46M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$2.60M derived: sum of 2 quarters · filed 2025-03-31 | -$3.77M derived: sum of 3 quarters · filed 2025-03-31 | -$4.44M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.43M 10-Q · filed 2024-11-14 | -$2.60M derived: sum of 2 quarters · filed 2024-11-14 | -$3.27M 10-Q · filed 2024-11-14 | -$3.93M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$1.17M 10-Q · filed 2024-08-14 | -$1.84M 10-Q · filed 2024-08-14 | -$2.50M derived: sum of 3 quarters · filed 2024-08-14 | -$3.59M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$669.95K 10-Q · filed 2024-05-15 | -$1.33M derived: sum of 2 quarters · filed 2024-05-15 | -$2.42M derived: sum of 3 quarters · filed 2024-05-15 | -$3.14M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$663.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | -$1.75M derived: sum of 2 quarters · filed 2024-05-14 | -$2.47M derived: sum of 3 quarters · filed 2024-05-14 | -$3.98M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | -$1.09M 10-Q · filed 2023-11-14 | -$1.81M derived: sum of 2 quarters · filed 2023-11-14 | -$3.32M 10-Q · filed 2023-11-14 | -$4.29M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$717.04K 10-Q · filed 2023-08-14 | -$2.23M 10-Q · filed 2023-08-14 | -$3.20M derived: sum of 3 quarters · filed 2023-08-14 | -$4.08M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$1.51M 10-Q · filed 2023-05-15 | -$2.48M derived: sum of 2 quarters · filed 2023-05-15 | -$3.36M derived: sum of 3 quarters · filed 2023-05-15 | -$4.91M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$966.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.85M derived: sum of 2 quarters · filed 2023-03-31 | -$3.39M derived: sum of 3 quarters · filed 2023-03-31 | -$4.60M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$880.06K 10-Q · filed 2022-11-14 | -$2.43M derived: sum of 2 quarters · filed 2022-11-14 | -$3.63M 10-Q · filed 2022-11-14 | -$4.16M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$1.55M 10-Q · filed 2022-08-11 | -$2.75M 10-Q · filed 2022-08-11 | -$3.28M derived: sum of 3 quarters · filed 2022-08-11 | -$4.32M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.21M 10-Q · filed 2022-05-13 | -$1.73M derived: sum of 2 quarters · filed 2022-05-13 | -$2.77M derived: sum of 3 quarters · filed 2022-05-13 | -$3.34M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$522.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | -$1.57M derived: sum of 2 quarters · filed 2022-04-07 | -$2.13M derived: sum of 3 quarters · filed 2022-04-07 | -$2.55M 10-K · filed 2022-04-07 | |
| 2020-09-30 | -$1.05M 10-Q · filed 2021-11-15 | -$1.61M derived: sum of 2 quarters · filed 2021-11-15 | -$2.03M 10-Q · filed 2021-11-15 | -$2.86M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$566.27K 10-Q · filed 2021-08-16 | -$1.07M 10-Q · filed 2021-08-16 | -$1.82M derived: sum of 3 quarters · filed 2021-08-16 | -$1.94M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$501.01K 10-Q · filed 2021-05-17 | -$1.25M derived: sum of 2 quarters · filed 2021-05-17 | -$1.37M derived: sum of 3 quarters · filed 2021-05-17 | -$1.65M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$749.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$872.44K derived: sum of 2 quarters · filed 2021-03-25 | -$1.15M derived: sum of 3 quarters · filed 2021-03-25 | -$1.76M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$123.33K 10-Q · filed 2020-11-16 | -$401.54K derived: sum of 2 quarters · filed 2020-11-16 | -$1.01M 10-Q · filed 2020-11-16 | -$1.80M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$278.21K 10-Q · filed 2020-08-14 | -$885.12K 10-Q · filed 2020-08-14 | -$1.68M derived: sum of 3 quarters · filed 2020-08-14 | -$2.18M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$606.90K 10-Q · filed 2020-06-18 | -$1.40M derived: sum of 2 quarters · filed 2020-06-18 | -$1.90M derived: sum of 3 quarters · filed 2020-06-18 | -$2.57M derived: sum of 4 quarters · filed 2020-06-18 | |
| 2018-12-31 | -$795.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | -$1.29M derived: sum of 2 quarters · filed 2020-04-29 | -$1.96M derived: sum of 3 quarters · filed 2020-04-29 | -$2.56M 10-K · filed 2020-04-29 | |
| 2018-09-30 | -$497.99K 10-Q · filed 2019-11-14 | -$1.17M derived: sum of 2 quarters · filed 2019-11-14 | -$1.77M 10-Q · filed 2019-11-14 | -$2.46M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$667.38K 10-Q · filed 2019-08-14 | -$1.27M 10-Q · filed 2019-08-14 | -$1.96M derived: sum of 3 quarters · filed 2019-08-14 | -$2.41M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$599.06K 10-Q · filed 2019-05-16 | -$1.30M derived: sum of 2 quarters · filed 2019-05-16 | -$1.74M derived: sum of 3 quarters · filed 2019-05-16 | -$2.19M derived: sum of 4 quarters · filed 2019-05-16 | |
| 2017-12-31 | -$697.09K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$1.14M derived: sum of 2 quarters · filed 2019-03-29 | -$1.59M derived: sum of 3 quarters · filed 2019-03-29 | -$2.25M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$447.55K 10-Q · filed 2018-11-08 | -$892.89K derived: sum of 2 quarters · filed 2018-11-08 | -$1.55M 10-Q · filed 2018-11-08 | -$2.11M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$445.34K 10-Q · filed 2018-08-14 | -$1.10M 10-Q · filed 2018-08-14 | -$1.66M derived: sum of 3 quarters · filed 2018-08-14 | -$2.17M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$655.82K 10-Q · filed 2018-05-15 | -$1.22M derived: sum of 2 quarters · filed 2018-05-15 | -$1.72M derived: sum of 3 quarters · filed 2018-05-15 | -$2.23M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$563.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.07M derived: sum of 2 quarters · filed 2018-04-02 | -$1.57M derived: sum of 3 quarters · filed 2018-04-02 | -$2.31M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$503.23K 10-Q · filed 2017-11-13 | -$1.01M derived: sum of 2 quarters · filed 2017-11-13 | -$1.75M 10-Q · filed 2017-11-13 | -$2.18M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | -$502.62K 10-Q · filed 2017-08-08 | -$1.24M 10-Q · filed 2017-08-08 | -$1.67M derived: sum of 3 quarters · filed 2017-08-08 | -$2.12M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | -$739.36K 10-Q · filed 2017-05-15 | -$1.17M derived: sum of 2 quarters · filed 2017-05-15 | -$1.62M derived: sum of 3 quarters · filed 2017-05-15 | -$1.71M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | -$430.18K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-05-08 | -$877.47K derived: sum of 2 quarters · filed 2017-05-08 | -$973.78K derived: sum of 3 quarters · filed 2017-05-08 | -$1.02M 10-K/A · filed 2017-05-08 | |
| 2015-09-30 | -$447.29K 10-Q · filed 2016-11-17 | -$543.60K derived: sum of 2 quarters · filed 2016-11-17 | -$594.31K 10-Q · filed 2016-11-17 | ||
| 2015-06-30 | -$96.30K 10-Q · filed 2016-08-15 | -$147.02K 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | -$50.72K 10-Q · filed 2016-07-25 | ||||
| 2014-12-31 | -$458.82K 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |